If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoca-Cola HBC Regulatory News (CCH)

Share Price Information for Coca-Cola HBC (CCH)

Share Price is delayed by 15 minutes
Get Live Data
5,140.00    182.00 (3.67%)
Bid:
5,100.00
Ask:
5,110.00
Spread: 10.00 (0.196%)
Market Cap: £18.73b
CCH Live PriceLast checked at - London Stock Exchange

Intraday Coca-Cola HBC Share Chart

Director Declaration

Today 12:20

RNS Number : 8205K
Coca-Cola HBC AG
02 July 2026
 

Coca-Cola HBC AG

Director Declaration

 

Zug, Switzerland - 2 July 2026 - Coca-Cola HBC AG ("Coca-Cola HBC") announces that Glykeria Tsernou, who is an independent non-executive director of Coca-Cola HBC, has been appointed to the board of Attica Department Stores SA.

Attica Department Stores SA shares have been listed and effective 2 July 2026 commenced trading on Euronext Athens. Glykeria Tsernou is an independent non-executive director, a member of the audit committee and a member of the remuneration and nomination committee of Attica Department Stores SA and has been appointed in these positions prior to Attica Department Stores SA's listing.

This disclosure is made in accordance with the Financial Conduct Authority's UK Listing Rule 6.4.9R.

 

 

Enquiries

Coca-Cola HBC Group

Investors and Analysts:

Jemima Benstead

Head of Investor Relations

Tel: +44 7740 535130

 jemima.benstead @cchellenic.com

Elias Davvetas

Investor Relations Manager

Tel: +30 694 7568826

elias.davvetas@cchellenic.com

Matilde Durazzano

Investor Relations Manager

 

Elizabeth King

Investor Relations Manager

 

Tel: +44 7851 105884

matilde.durazzano@cchellenic.com

 

Tel: +44 7864 686582

elizabeth.king@cchellenic.com

Media:

Claire Evans

Head of Corporate Communications

Tel: +44 7896 054 972

claire.evans @cchellenic.com

 

About Coca‑Cola HBC

Coca-Cola HBC is a growth-focused consumer packaged goods business and strategic bottling partner of

The Coca-Cola Company. We open up moments that refresh us all, by creating value for our stakeholders and supporting the socio-economic development of the communities in which we operate. With a vision to be the leading 24/7 beverage partner, we offer drinks for all occasions around the clock and work together with our customers to serve 760 million consumers across a broad geographic footprint of 29 countries. Our portfolio is one of the strongest, broadest and most flexible in the beverage industry, with consumer-leading brands across the sparkling, adult sparkling, juice, water, sport, energy, ready-to-drink tea, coffee, and premium spirits categories, with snacks as an additional offering. Our products include Coca-Cola, Coca-Cola Zero Sugar, Fanta, Sprite, Schweppes, Kinley, Costa Coffee, Caffè Vergnano, Valser, FuzeTea, Powerade, Cappy, Monster Energy, Finlandia Vodka, The Macallan, Jack Daniel's and Plazma. We foster an open and inclusive work environment for our more than 33,500 employees and believe that a positive environmental impact is integral to our future growth. We are among the leaders of the global beverage industry across major sustainability benchmarks, including the Dow Jones Best-in-Class Indices, CDP, MSCI ESG, FTSE ESG and ISS ESG.

 

Coca-Cola HBC is listed on the London Stock Exchange (LSE: CCH) and on Euronext Athens (Euronext Athens: EEE). For more information, please visit https://www.coca-colahellenic.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RDNBGGDRRUGDGLD
Date   Source Headline
23rd Dec 20252:45 pmRNSDirector/PDMR Shareholding
23rd Dec 20252:45 pmRNSDirector/PDMR Shareholding
22nd Dec 20252:15 pmRNSDirector/PDMR Shareholding
22nd Dec 20252:15 pmRNSDirector/PDMR Shareholding
18th Dec 20255:00 pmRNSDirector/PDMR Shareholding
18th Dec 20255:00 pmRNSDirector/PDMR Shareholding
18th Dec 20253:15 pmRNSDirector/PDMR Shareholding
18th Dec 20253:15 pmRNSDirector/PDMR Shareholding
17th Dec 20257:00 amRNSNotice of EGM
24th Nov 20252:15 pmRNSDirector/PDMR Shareholding
18th Nov 20254:10 pmRNSDirector/PDMR Shareholding
5th Nov 20251:45 pmRNSDirector/PDMR Shareholding
3rd Nov 20259:30 amRNSBlock listing Interim Review
30th Oct 20253:00 pmRNSHolding(s) in Company
23rd Oct 20252:10 pmRNSDirector/PDMR Shareholding
23rd Oct 20252:00 pmRNSDirector/PDMR Shareholding
21st Oct 20257:03 amRNSSolid Q3 performance; guidance reiterated
21st Oct 20257:00 amRNSCCH to acquire Coca-Cola Beverages Africa
20th Oct 20253:45 pmRNSDirector/PDMR Shareholding
30th Sep 202511:30 amRNSNotice of Results
18th Sep 20252:30 pmRNSDirector/PDMR Shareholding
19th Aug 202512:00 pmRNSDirector/PDMR Shareholding
6th Aug 20257:00 amRNSConsistent execution delivers strong H1 results
4th Aug 20254:45 pmRNSRevolving Credit Facility
18th Jul 202512:15 pmRNSDirector/PDMR Shareholding
15th Jul 20251:00 pmRNSBitesize Investor Series – Nigeria
7th Jul 20251:09 pmRNSNotice of Results
3rd Jul 202510:04 amRNSHolding(s) in Company
2nd Jul 20253:29 pmRNSHolding(s) in Company
30th Jun 20253:32 pmRNSDirector/PDMR Shareholding
30th Jun 20251:44 pmRNSHolding(s) in Company
18th Jun 20252:55 pmRNSDirector/PDMR Shareholding
3rd Jun 20251:19 pmRNSDirector/PDMR Shareholding
2nd Jun 20258:07 amRNSTransfer of treasury shares & total voting rights
23rd May 20252:05 pmRNSComposition of the Board Committees
23rd May 20251:55 pmRNSResult of AGM and dividend dates
20th May 20252:37 pmRNSDirector/PDMR Shareholding
19th May 202512:22 pmRNSDirector/PDMR Shareholding
7th May 20252:33 pmRNSDirector/PDMR Shareholding
1st May 20259:37 amRNSBlock listing Interim Review
1st May 20259:23 amRNSTransfer of treasury shares & total voting rights
30th Apr 20257:00 amRNSStrong start; reiterating 2025 guidance
23rd Apr 20251:38 pmRNSAGM Notice,changes to BoD,dividend dates-Amendment
23rd Apr 20257:00 amRNSNotice of AGM, changes to the BoD, dividend dates
22nd Apr 202512:42 pmRNSDirector/PDMR Shareholding
2nd Apr 202510:13 amRNSNotice of Results
1st Apr 20259:23 amRNSTransfer of treasury shares & total voting rights
28th Mar 20252:43 pmRNSDirector/PDMR Shareholding
28th Mar 20252:42 pmRNSDirector/PDMR Shareholding
28th Mar 20252:37 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.